2108 Reports20and20Data20logo 89

The paradigm shift from clipping to coiling and increased demand for minimally invasive surgeries has augmented the demand for the market.

The global Liquid Embolic market is forecast to reach USD 3.27 Billion by 2027, according to a new report by Reports and Data. Embolization is a minimally invasive, non-surgical procedure that involves the selective occlusion of blood vessels, by purposely introducing emboli. The procedure is an alternative to open surgery and is performed by interventional neuroradiologists. Liquid embolic products are used for the embolization of both arterio-venous malformations (AVMs) and aneurysms.

Liquid embolic agents include ethylene vinyl alcohol and cyanoacrylate. These agents are used to prevent blood supply to aneurysm or tumor. It helps in suppressing the growth and any adverse effects suffered by aneurysms and tumors to vital organs. Liquid embolic agents have the advantage over the flexibility and expense, as well as the threat of vascular injury during navigation. The market is expected to grow due to the increasing adoption of liquid embolic agents due to the favorable clinical research results. The growing prevalence of arteriovenous malformation, growth in the incidence of tumors, and aneurysms factors are also driving the growth of the market.

However, liquid embolic agents are not compatible with everyone, and there lies a potential risk in embolization of untargeted blood cells. This may limit the market growth. Moreover, insufficient supply and shortage of manufacturers are also factors hindering the growth of the market.

 Get a sample copy of the global Liquid Embolic market report @ https://www.reportsanddata.com/sample-enquiry-form/2690

Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.

Key participants

Medtronic, Cyberonics, InoMed, Boston Scientific, Codman, and Shurtleff. RauMedic, St. Jude Medical, Stryker, Mizuho America, and Integra LifeSciences, among others.

Further key findings from the report suggest

Brain Arteriovenous Malformations is the tangle of abnormal blood vessels that connect veins and arteries in the brain. They can develop anywhere in the body and but occurs generally in the spine or brain. The disease are rare and affects less than one percent of the population.

Hospitals held a major market share as these sophisticated devices are available in bigger hospitals and critical care units. The increasing adoption of minimally invasive surgeries, increase in the purchasing power, and investment into the healthcare sector is boosting the growth of the market.

Sodium Morrhuate is consumed mainly by injection and is a mixture of salts of the saturated and unsaturated fatty acids of cod liver oil. It is a pale yellow, granular powder with a slight fishy odor and is soluble in water and alcohol.

North America held the largest market share due to the availability of advanced equipment and quicker adoption of innovative surgeries. The region also invest in research and development heavily.

The U.S. is the largest market for liquid embolic products. The growth of the market forecasts estimate that the major share of liquid embolic sales are related to the products for the treatment of approved neurovascular indications. However, primary research suggests that off-label usage of liquid embolic agents accounts for a significant percentage of overall utilization.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2690

For the purpose of this report, Reports and Data have segmented into the global Liquid Embolic market on the basis of product, application, end-users, and region:

Product Outlook (Revenue, USD Billion; 2016-2027)


Sodium Morrhuate


Bletilla Striata

Application Outlook (Revenue, USD Billion; 2016-2027)

Brain Arteriovenous Malformations

Tumor and Brain Cancer

Brain Aneurysm

Ischemic Stroke

End Users Outlook (Revenue, USD Billion; 2016-2027)


Ambulatory Surgical Centers

Regional Outlook (Revenue, USD Billion; 2016-2027)

North America


Asia Pacific


Latin America

Major Highlights of the Liquid Embolic Market Report:

The Liquid Embolic market analysis report offers an in-depth study of the potential market growth opportunities and challenges.

The report dives deeper into the market and explains the dynamic factors bolstering market growth.

The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.

The report analyzes the Liquid Embolic market presence across major regions of the world.

It determines the production & consumption capacities and demand & supply dynamics of each regional market.

The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.

It provides company overview and SWOT analysis of each of the market players.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2690

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Read More Reports:-

Transfer Membrane Market @ https://www.biospace.com/article/transfer-membrane-market-size-to-reach-usd-204-75-million-in-2028-noted-reports-and-data/

Nuclear Imaging Equipment Market @ https://www.biospace.com/article/nuclear-imaging-equipment-market-size-to-reach-usd-3-5-billion-in-2028-says-reports-and-data/

Capillary Blood Collection Market @ https://www.biospace.com/article/capillary-blood-collection-market-size-to-value-at-usd-2-10-billion-in-2028/

Lung In Vitro Model Market @ https://www.biospace.com/article/lung-in-vitro-market-size-to-reach-usd-976-9-million-in-2028-says-reports-and-data/

Organs-on-Chips Market @ https://www.biospace.com/article/organs-on-chips-market-size-to-value-at-usd-294-75-million-in-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Tags: Asia-Pacific Liquid Embolic Market, Liquid Embolic Market After COVID-19, COVID-19 Effect On Industry Liquid Embolic Market, Europe Liquid Embolic Market, Liquid Embolic Industry, Liquid Embolic Market 2021, Liquid Embolic Market Analysis

See Campaign: https://www.reportsanddata.com/report-detail/liquid-embolic-market
Contact Information:

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Menafn, Reportedtimes, PR-Wirein, iCN Internal Distribution, Research Newswire, English